Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Severe Behaviors in Autism
NCT07091279Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in Autism Spectrum Disorder (ASD). Started Jan 2026; status: recruiting.
02
Drugs
propranolol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07091279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07091279.